Pharmaffiliates

Zotiraciclib

Zotiraciclib also known as TG02 or SB1317. it is an investigational oral drug being developed for the treatment of aggressive cancers, particularly gliomas and other brain tumors. Reference standards of Zotiraciclib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Zotiraciclib
    [catalogue_number] => PA 26 0530000
    [category_ids] => ,79,80,71,81,78,70,82,
    [chemical_name] => 
    [weight] => 372.47
    [form] => C23H24N4O
    [cas] => 1204918-72-8
    [pslug] => 1204918-72-8-zotiraciclib-pa260530000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 26 0530000

Zotiraciclib


  • Catalogue No.:PA 26 0530000

  • CAS :

    1204918-72-8

  • Molecular Formula : C23H24N4O

  • Molecular Weight : 372.47

stdClass Object
(
    [pname] => (E/Z)-Zotiraciclib
    [catalogue_number] => PA 26 0531000
    [category_ids] => ,79,80,71,81,78,70,82,
    [chemical_name] => 
    [weight] => 372.47
    [form] => C23H24N4O
    [cas] => 937270-47-8
    [pslug] => 937270-47-8-e-z-zotiraciclib-pa260531000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 26 0531000

(E/Z)-Zotiraciclib


  • Catalogue No.:PA 26 0531000

  • CAS :

    937270-47-8

  • Molecular Formula : C23H24N4O

  • Molecular Weight : 372.47